← Back to Clinical Trials
Recruiting NCT05005026

NCT05005026 Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05005026
Status Recruiting
Phase
Sponsor Texas A&M University
Condition Spinal Cord Injuries
Study Type INTERVENTIONAL
Enrollment 250 participants
Start Date 2021-11-23
Primary Completion 2026-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
VR Game 1VR Game 2

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 250 participants in total. It began in 2021-11-23 with a primary completion date of 2026-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to determine if playing a virtual reality walking game can help improve neuropathic pain in adults with chronic spinal cord injury.

Eligibility Criteria

Inclusion Criteria: The study will recruit individuals with complete injury (American Spinal Injury Association \[ASIA\] classification A) with lumbar, paraplegic, or low tetraplegic (C5-C7) injury. Additional criteria will include: 1. Must have persistent NP symptoms that are of daily severity of at least 4/10 for 3 or more months 2. Must endorse more than 2 items on a 7-item Spinal Cord Injury Pain Instrument, SCIPI 3. Must be 18 years of age or older 4. Must be more than one year post-injury to begin study (can be screened at an earlier time for eligibility) 5. Must have mobile connectivity with usable service 6. Must be stable on pain medication for 1 or more months 7. Must be cleared on the VRWalk physical activity clearance scale 8. Must not have motion sickness that interferes with daily life Exclusion Criteria: 1. Individuals with Injury levels between C1 and C4 2. Individuals under the age of 18 3. Individuals who were injured within the past year 4. Individuals who cannot comprehend spoken English 5. Individuals who are in prison 6. Individuals who are blind 7. Individuals who experience severe motion sickness

Contact & Investigator

Central Contact

Amanda Sainz-Higgins, M.E.d

✉ sci@vrwalk.org

📞 804-569-5965

Principal Investigator

Zina Trost, PhD

PRINCIPAL INVESTIGATOR

Texas A&M University

Frequently Asked Questions

Who can join the NCT05005026 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Cord Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05005026 currently recruiting?

Yes, NCT05005026 is actively recruiting participants. Contact the research team at sci@vrwalk.org for enrollment information.

Where is the NCT05005026 trial being conducted?

This trial is being conducted at Birmingham, United States, College Station, United States, Sydney, Australia.

Who is sponsoring the NCT05005026 clinical trial?

NCT05005026 is sponsored by Texas A&M University. The principal investigator is Zina Trost, PhD at Texas A&M University. The trial plans to enroll 250 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology